STING1 and melanoma: Importantly, intraperitoneal injection of SR‐717 at therapeutic doses led to elevated plasma IFN production and robust STING‐mediated antitumor responses in syngeneic mouse models of MC38 colorectal adenocarcinoma and B16‐F10 melanoma.